INTUITIVE SURGICAL INC
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $10.1B | $8.4B | $7.1B | $6.2B | $5.7B |
| Gross profit | $6.6B | $5.6B | $4.7B | $4.2B | $4.0B |
| Operating income | $2.9B | $2.3B | $1.8B | $1.6B | $1.8B |
| Operating expenses | $3.7B | $3.3B | $3.0B | $2.6B | $2.1B |
| Cost of revenue | $3.4B | $2.7B | $2.4B | $2.0B | $1.8B |
| Cash from operations | $3.0B | $2.4B | $1.8B | $1.5B | $2.1B |
| Capital expenditure | $539.8M | $1.1B | $1.1B | $532.4M | $339.5M |
| Free cash flow | $2.5B | $1.3B | $749.6M | $958.4M | $1.7B |
| Share repurchases | $2.3B | $0 | $416.3M | $2.6B | $0 |
| Impairments | $0 | $0 | $0 | — | — |
| Total assets | $20.5B | $18.7B | $15.4B | $13.0B | $13.6B |
| Total liabilities | $2.5B | $2.2B | $2.0B | $1.9B | $1.6B |
Shares outstanding 354.2M · Free float 99.9%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.